A Track Star, Doping Allegations, & The NCAA’s Anti-Doping Policy Exposed

Why It Matters

The case exposes a loophole that lets athletes potentially evade sanctions by transferring, undermining the integrity of college sports and prompting calls for stricter, uniform anti‑doping enforcement.

Key Takeaways

• Clevenger set DIII 5,000 m record after transferring.
• Former teammates allege peptide and EPO use at Iowa State.
• NCAA bans lack uniform penalties; transfers avoid suspensions.
• USADA says it has no jurisdiction over NCAA cases.
• Petition urges investigation, exposing anti‑doping policy flaws.

Pulse Analysis

The controversy surrounding Seth Clevenger underscores how high‑profile performances can mask underlying compliance issues in collegiate athletics. While Clevenger’s 13:32.09 5,000 m run and sub‑four‑minute mile have propelled Rowan University into national contention, anonymous teammates from his Iowa State days allege he experimented with BPC‑157, a peptide prohibited under both NCAA and WADA regulations, and stored EPO in his refrigerator. These claims, bolstered by a purported email receipt, have ignited a debate about the adequacy of current testing protocols and the transparency of institutional investigations.

At the heart of the dispute lies the NCAA’s fragmented anti‑doping framework. Unlike professional bodies that enforce the World Anti‑Doping Code, the NCAA imposes a one‑year ban only after a positive test result, while admissions or suspicions are handled internally by each school. This structure permits athletes who acknowledge substance use to transfer to another institution and compete immediately, provided they remain academically eligible. USADA’s admission of limited jurisdiction further weakens enforcement, as the agency cannot sanction athletes whose primary affiliation is collegiate, leaving the NCAA as the sole arbiter of discipline.

The broader implications extend beyond a single runner. With the rise of name‑image‑likeness (NIL) deals funneling millions into college sports, the temptation to seek performance enhancements grows, intensifying pressure on athletes and administrators alike. Stakeholders—including athletes, coaches, and governing bodies—are calling for reforms such as independent testing agencies, mandatory reporting of non‑analytical violations, and standardized penalties that follow athletes across institutions. Addressing these gaps is essential to preserve competitive fairness, protect athlete health, and maintain public confidence in the collegiate sports system.